drugset / Trial / NCT00037804

Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction

NCT00037804 ↗

Phase 1 Completed Pfizer
Treatment

Summary

Drugs used in chemotherapy us different ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may be effective in treating patients with refractory solid tumors and liver dysfunction.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule — —